{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Avalon GloboCare Corp."},"Symbol":{"label":"Symbol","value":"ALBT"},"Address":{"label":"Address","value":"4400 ROUTE 9 SOUTH,SUITE 3100, FREEHOLD, New Jersey, 07228, United States"},"Phone":{"label":"Phone","value":"732-780-4400"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Avalon GloboCare Corp. (OTCQB: AVCO) is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative cell-based technologies and their clinical applications, as well as healthcare facility management through its core platforms, namely 'Avalon Cell' and 'Avalon Rehab."},"CompanyUrl":{"label":"Company Url","value":"https://www.avalon-globocare.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David K. Jin","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}